Valeria Visconte
@viscontevaleria
PhD, Staff @ClevelandClinic; Assistant Prof @CCLCM of @CWRUSOM; translational hematology: bone marrow failure disorders/MDS/AML/genomics/Clonal hematopoiesis
ID: 1336140697636888576
https://www.lerner.ccf.org/translational-hematology-oncology/visconte/ 08-12-2020 02:49:11
349 Tweet
222 Takipçi
263 Takip Edilen
Mikkael A. Sekeres MD, MS and Toyosi Odenike are excited to welcome you to this insightful event bringing together top experts in bone marrow failure. Register today at aamdsif.salsalabs.org/2025bmfsummit
Newsweek has ranked Cleveland Clinic as the #2 hospital in the world. This recognition is a reflection of our caregivers, who form the heart and soul of our organization. Their dedication to excellence and compassion are the pillars of our care. More: bit.ly/43n8n05
Congratulations Vik Dhillon Abdulmoiz! Differential prognostic impact of NPM1-MT AML underscores the need for age-adapted risk stratification models MDPI Jeff Aguilar Sushmitha Nanja Reddy Julie Boerner Carmelo Gurnari Waled Bahaj, MD tariqkewan Valeria Visconte
Check out our comprehensive review on #AML from an MD Anderson Cancer Center perspective, " Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges" published in ACS Journal Cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #leusm
I am thrilled to share our new publication in @eClinicalMedicine co-led with a superb Vanderbilt Health IM resident James Brogan: "Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis" sciencedirect.com/science/articl… We analyzed 805,249 participants
Our new paper on the use of ATG in immune-mediated cytopenias is out! Valeria Visconte Carmelo Gurnari Serhan Unlu onlinelibrary.wiley.com/doi/10.1111/bj…
🙏 Jake Scott for riding 💯 miles VeloSano to support #cancer research Cleveland Clinic! #CleClinicCancer
Happy to share my lab’s work out today in Cancer Cell demonstrating that multiple myeloma relapses after CAR T therapy frequently express low BCMA levels. We develop novel SEMA4A-directed CAR T cells eradicating MM, especially under BCMA low conditions. authors.elsevier.com/a/1lvYf_YwcvnX…